EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.4750
+0.0250 (5.56%)
Jul 15, 2026, 10:33 AM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 21.18 million as of July 14, 2026. Its market cap has decreased by -81.75% in one year.
Market Cap
21.18M
Enterprise Value
6.63M
Revenue
61.40M
Ranking
n/a
PE Ratio
7.33
Stock Price
0.48
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 21.18M, a decrease of -56.53%. That is a compound annual growth rate of -14.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 21.18M | -68.07% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 33.86M |
| Noxopharm | 27.96M |
| Patrys | 26.66M |
| Algorae Pharmaceuticals | 26.33M |
| Neurotech International | 22.40M |
| NeuroScientific Biopharmaceuticals | 21.62M |
| Argenica Therapeutics | 16.06M |
| Immuron | 14.05M |